What changed
Adjusted EPS of $2.51 beat consensus by $0.12 (5%), driven by strong Commercial and Medicare margins. Revenue of $44.4B rose 4% YoY, with guidance raised to >$4.80 adjusted EPS, reflecting underlying strength. The key nuance: ~$0.50 of the guidance increase stems from non-recurring items in Medicare and Commercial, masking core operating trends.
Why it matters
Adjusted EPS of $2.51 beat consensus by $0.12 (5%), driven by strong Commercial and Medicare margins. Revenue of $44.4B rose 4% YoY, with guidance raised to >$4.80 adjusted EPS, reflecting underlying strength. The key nuance: ~$0.50 of the guidance increase stems from non-recurring items in Medicare and Commercial, masking core operating trends.